Mount Sinai’s Wien Center for Alzheimer’s Disease and Memory Disorders will host their first ever public education forum on the prevention of Alzheimer’s disease. The public forum is a new addition to the ongoing medical symposium hosted by the Wien Center that is now entering its eleventh year – the Mild Cognitive Impairment (MCI) Syposium -, which welcomes neurological medical experts from around the world to gather and share new information about advances in research related to the clinical diagnosis and progression of Alzheimer’s disease.
The public education forum will be held on Sunday, January 20th, from 2:00 p.m. – 5:30 p.m. at the Miami Beach Resort and Spa located at 4833 Collins Avenue. Attendance is free. The forum was created to present members of the community who have an interest in Alzheimer’s disease with the most up-to-date information on the biology of the disease, treatment options and the plans for launching three new clinical trials designed to prevent the development of Alzheimer’s.
“People with MCI are at increased risk for progressing to Alzheimer’s or dementia,” said Dr. Ranjan Duara, Mount Sinai Medical Director for the Wien Center and host of the public educational forum. “The information shared at our public forum can be a tremendous benefit to those who may be at risk, or have family members at risk of developing Alzheimer’s disease.”
Medical experts from around the country will discuss various topics related to Alzheimer’s disease and be on hand to interact with the audience. Dr. Susan Landau, research scientist at the Helen Wills Neuroscience Institute at the University of California, Berkeley, will kick off the forum with a discussion on the relationship between aging and mild cognitive impairment. Dr. Reisa Sperling, Director of the Center for Alzheimer’s Research and Treatment at Massachusetts General Hospital, will follow with a presentation on how to treat Alzheimer’s before symptoms begin. Dr. Allan Levy, professor and chair of the department of neurology at Emory University School of Medicine will discuss what we know about the genetics of Alzheimer’s disease. The program will conclude with Dr. Maria Castillo, outreach specialist from the National Alzheimer’s Association, who will present information on three new clinical trials that will study the prevention of symptomatic Alzheimer’s disease among individuals who are at elevated risk. All medical experts will be available for a panel discussion and answer audience questions.
To register for the Mount Sinai Alzheimer’s Public Education Forum, visit www.mcisymposium.org/forum or call Julia Salas at 305-674-2121, ext. 54461.
